Clinical Trial

Wireless Irradiance SEnsors During Neonatal Phototherapy

Study acronym: WISE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Bilisensors are devices designed to measure the cumulative dose of phototherapy administered to neonates undergoing treatment for hyperbilirubinemia. The current standard of care typically involves intermittent spot measurements once a day using a handheld dosimeter that may give variable estimations. In contrast, bilisensors may enable continuous, real-time monitoring of light exposure, helping to know the total phototherapy dose received by the infant.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-30.
Status change: Not Yet Recruiting → Active, Not Recruiting 2026-05-05
Trial Details
NCT Number NCT07057635
Lead Sponsor McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions Neonatal Hyperbilirubinemia, Jaundice, Neonatal, Phototherapy Complication, Newborn Complication
Enrollment 9 participants
Start Date 2025-07-10
Primary Completion 2025-12-10 (estimated)
Study Completion 2026-09-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-08